JBS N.V.

JBS trades at a remarkably depressed 8.49x earnings—among the cheapest valuations in global meat processing—yet RSI of 40.7 signals the stock remains far from oversold territory. With 8.89% short interest and a market cap of $17.2B, the setup suggests neither extreme complacency nor acute squeeze risk. The combination of deep value metrics alongside neutral momentum readings implies the market is pricing in either structural headwinds (regulatory, commodity cost volatility, or execution concerns) or genuine indifference. A catalyst-driven re-rating could trigger meaningful upside if fundamentals stabilize, but the low multiples alone aren't screaming bargain without clarity on why the market is content to ignore them.